Compare YSWY & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YSWY | IMTX |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2021 | 2020 |
| Metric | YSWY | IMTX |
|---|---|---|
| Price | $24.91 | $9.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $19.00 |
| AVG Volume (30 Days) | 354.2K | ★ 489.8K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $25.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.92 | $5.05 |
| 52 Week High | $26.34 | $12.41 |
| Indicator | YSWY | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 67.06 | 51.49 |
| Support Level | $19.41 | $9.37 |
| Resistance Level | $26.34 | $10.41 |
| Average True Range (ATR) | 1.29 | 0.39 |
| MACD | 0.27 | -0.03 |
| Stochastic Oscillator | 88.79 | 63.29 |
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.